Annual Operating Profit
-$496.20 M
-$172.00 M-53.05%
31 December 2023
Summary:
Cytokinetics Incorporated annual operaing income is currently -$496.20 million, with the most recent change of -$172.00 million (-53.05%) on 31 December 2023. During the last 3 years, it has fallen by -$402.26 million (-428.20%). CYTK annual operating profit is now -2003.21% below its all-time high of $26.07 million, reached on 31 December 2009.CYTK Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$140.80 M
-$10.63 M-8.17%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly operating income is currently -$140.80 million, with the most recent change of -$10.63 million (-8.17%) on 30 September 2024. Over the past year, it has dropped by -$18.54 million (-15.16%). CYTK quarterly operating profit is now -344.44% below its all-time high of $57.60 million, reached on 30 June 2009.CYTK Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$524.63 M
-$18.54 M-3.66%
30 September 2024
Summary:
Cytokinetics Incorporated TTM operating income is currently -$524.63 million, with the most recent change of -$18.54 million (-3.66%) on 30 September 2024. Over the past year, it has dropped by -$28.81 million (-5.81%). CYTK TTM operating profit is now -2020.86% below its all-time high of $27.31 million, reached on 30 September 2009.CYTK TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.0% | -15.2% | -5.8% |
| 3 y3 years | -428.2% | -103.5% | -161.0% |
| 5 y5 years | -458.1% | -488.5% | -443.0% |
CYTK Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -428.2% | at low | -1194.8% | at low | -192.1% | at low |
| 5 y | 5 years | -458.1% | at low | -2816.1% | at low | -545.8% | at low |
| alltime | all time | -2003.2% | at low | -344.4% | at low | -2020.9% | at low |
Cytokinetics Incorporated Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$140.80 M(+8.2%) | -$524.63 M(+3.7%) |
| June 2024 | - | -$130.17 M(+3.1%) | -$506.09 M(+1.6%) |
| Mar 2024 | - | -$126.23 M(-0.9%) | -$497.97 M(+0.4%) |
| Dec 2023 | -$496.20 M(+53.1%) | -$127.42 M(+4.2%) | -$496.20 M(+0.1%) |
| Sept 2023 | - | -$122.27 M(+0.2%) | -$495.82 M(+2.9%) |
| June 2023 | - | -$122.05 M(-1.9%) | -$481.99 M(+30.0%) |
| Mar 2023 | - | -$124.47 M(-2.0%) | -$370.82 M(+14.4%) |
| Dec 2022 | -$324.20 M(+74.0%) | -$127.03 M(+17.1%) | -$324.20 M(+48.1%) |
| Sept 2022 | - | -$108.44 M(+897.3%) | -$218.88 M(+21.8%) |
| June 2022 | - | -$10.87 M(-86.0%) | -$179.64 M(-19.6%) |
| Mar 2022 | - | -$77.86 M(+258.7%) | -$223.56 M(+20.0%) |
| Dec 2021 | -$186.31 M(+98.3%) | -$21.70 M(-68.6%) | -$186.31 M(-7.3%) |
| Sept 2021 | - | -$69.20 M(+26.3%) | -$201.02 M(+58.7%) |
| June 2021 | - | -$54.80 M(+34.9%) | -$126.63 M(+21.5%) |
| Mar 2021 | - | -$40.61 M(+11.5%) | -$104.19 M(+10.9%) |
| Dec 2020 | -$93.94 M(-5.0%) | -$36.41 M(-802.3%) | -$93.94 M(+15.6%) |
| Sept 2020 | - | $5.18 M(-116.0%) | -$81.24 M(-26.4%) |
| June 2020 | - | -$32.36 M(+6.6%) | -$110.35 M(+5.4%) |
| Mar 2020 | - | -$30.36 M(+28.1%) | -$104.71 M(+5.9%) |
| Dec 2019 | -$98.87 M(+11.2%) | -$23.71 M(-0.9%) | -$98.87 M(+2.3%) |
| Sept 2019 | - | -$23.93 M(-10.4%) | -$96.62 M(+6.6%) |
| June 2019 | - | -$26.72 M(+9.0%) | -$90.61 M(+3.8%) |
| Mar 2019 | - | -$24.52 M(+14.3%) | -$87.30 M(-1.8%) |
| Dec 2018 | -$88.92 M(-21.6%) | -$21.46 M(+19.8%) | -$88.92 M(-14.5%) |
| Sept 2018 | - | -$17.91 M(-23.5%) | -$103.98 M(-9.2%) |
| June 2018 | - | -$23.41 M(-10.4%) | -$114.50 M(-1.5%) |
| Mar 2018 | - | -$26.13 M(-28.5%) | -$116.28 M(+2.5%) |
| Dec 2017 | -$113.40 M(-706.8%) | -$36.53 M(+28.5%) | -$113.40 M(+63.9%) |
| Sept 2017 | - | -$28.42 M(+12.8%) | -$69.18 M(+918.6%) |
| June 2017 | - | -$25.19 M(+8.4%) | -$6.79 M(-191.9%) |
| Mar 2017 | - | -$23.25 M(-402.4%) | $7.39 M(-60.5%) |
| Dec 2016 | $18.69 M(-150.0%) | $7.69 M(-77.4%) | $18.69 M(+844.3%) |
| Sept 2016 | - | $33.97 M(-408.5%) | $1.98 M(-104.8%) |
| June 2016 | - | -$11.01 M(-7.9%) | -$40.87 M(+1.0%) |
| Mar 2016 | - | -$11.95 M(+32.5%) | -$40.45 M(+8.1%) |
| Dec 2015 | -$37.41 M(+153.5%) | -$9.02 M(+1.5%) | -$37.41 M(+87.4%) |
| Sept 2015 | - | -$8.89 M(-16.1%) | -$19.96 M(+16.9%) |
| June 2015 | - | -$10.59 M(+18.9%) | -$17.07 M(+14.7%) |
| Mar 2015 | - | -$8.91 M(-205.8%) | -$14.89 M(+0.9%) |
| Dec 2014 | -$14.75 M(-56.5%) | $8.42 M(-240.4%) | -$14.75 M(-11.9%) |
| Sept 2014 | - | -$6.00 M(-28.7%) | -$16.74 M(-28.3%) |
| June 2014 | - | -$8.41 M(-4.1%) | -$23.36 M(-22.2%) |
| Mar 2014 | - | -$8.77 M(-236.3%) | -$30.02 M(-11.4%) |
| Dec 2013 | -$33.89 M | $6.43 M(-151.0%) | -$33.89 M(-34.6%) |
| Sept 2013 | - | -$12.61 M(-16.3%) | -$51.81 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$15.07 M(+19.1%) | -$49.28 M(+14.1%) |
| Mar 2013 | - | -$12.65 M(+10.1%) | -$43.18 M(+6.6%) |
| Dec 2012 | -$40.51 M(-13.4%) | -$11.49 M(+14.0%) | -$40.51 M(+2.0%) |
| Sept 2012 | - | -$10.07 M(+12.3%) | -$39.73 M(-1.5%) |
| June 2012 | - | -$8.97 M(-10.1%) | -$40.32 M(-10.4%) |
| Mar 2012 | - | -$9.98 M(-6.8%) | -$45.00 M(-3.8%) |
| Dec 2011 | -$46.77 M(-5.8%) | -$10.71 M(+0.3%) | -$46.77 M(-1.9%) |
| Sept 2011 | - | -$10.67 M(-21.8%) | -$47.70 M(-3.8%) |
| June 2011 | - | -$13.65 M(+16.1%) | -$49.60 M(+1.0%) |
| Mar 2011 | - | -$11.75 M(+1.0%) | -$49.10 M(-1.1%) |
| Dec 2010 | -$49.63 M(-290.4%) | -$11.63 M(-7.4%) | -$49.63 M(-1.5%) |
| Sept 2010 | - | -$12.56 M(-4.5%) | -$50.40 M(+9.4%) |
| June 2010 | - | -$13.15 M(+7.1%) | -$46.07 M(-286.6%) |
| Mar 2010 | - | -$12.28 M(-0.9%) | $24.69 M(-5.3%) |
| Dec 2009 | $26.07 M(-146.1%) | -$12.40 M(+50.7%) | $26.07 M(-4.5%) |
| Sept 2009 | - | -$8.23 M(-114.3%) | $27.31 M(+28.1%) |
| June 2009 | - | $57.60 M(-628.4%) | $21.32 M(-140.8%) |
| Mar 2009 | - | -$10.90 M(-2.3%) | -$52.32 M(-7.6%) |
| Dec 2008 | -$56.61 M(+0.2%) | -$11.16 M(-21.5%) | -$56.61 M(-6.3%) |
| Sept 2008 | - | -$14.22 M(-11.3%) | -$60.41 M(+1.7%) |
| June 2008 | - | -$16.04 M(+5.6%) | -$59.38 M(+2.5%) |
| Mar 2008 | - | -$15.19 M(+1.6%) | -$57.91 M(+2.5%) |
| Dec 2007 | -$56.49 M(-7.9%) | -$14.96 M(+13.3%) | -$56.49 M(-3.5%) |
| Sept 2007 | - | -$13.20 M(-9.4%) | -$58.51 M(-4.6%) |
| June 2007 | - | -$14.56 M(+5.8%) | -$61.31 M(-0.5%) |
| Mar 2007 | - | -$13.76 M(-18.9%) | -$61.63 M(+0.5%) |
| Dec 2006 | -$61.34 M(+37.4%) | -$16.98 M(+6.1%) | -$61.34 M(+9.4%) |
| Sept 2006 | - | -$16.00 M(+7.5%) | -$56.05 M(+10.4%) |
| June 2006 | - | -$14.89 M(+10.6%) | -$50.78 M(+8.1%) |
| Mar 2006 | - | -$13.47 M(+15.2%) | -$46.99 M(+5.3%) |
| Dec 2005 | -$44.63 M(+16.1%) | -$11.70 M(+9.0%) | -$44.63 M(-1.3%) |
| Sept 2005 | - | -$10.73 M(-3.4%) | -$45.23 M(+0.2%) |
| June 2005 | - | -$11.10 M(-0.1%) | -$45.15 M(+3.6%) |
| Mar 2005 | - | -$11.11 M(-9.6%) | -$43.57 M(+13.4%) |
| Dec 2004 | -$38.43 M(+17.9%) | -$12.29 M(+15.3%) | -$38.43 M(-42.3%) |
| Sept 2004 | - | -$10.65 M(+11.9%) | -$66.67 M(+24.9%) |
| June 2004 | - | -$9.52 M(+59.5%) | -$53.37 M(+9.9%) |
| Mar 2004 | - | -$5.97 M(-85.3%) | -$48.58 M(+2.0%) |
| Dec 2003 | -$32.59 M(+35.9%) | -$40.52 M(-1632.6%) | -$47.62 M(+571.1%) |
| Sept 2003 | - | $2.64 M(-155.9%) | -$7.09 M(-27.1%) |
| June 2003 | - | -$4.73 M(-5.5%) | -$9.74 M(+94.5%) |
| Mar 2003 | - | -$5.01 M | -$5.01 M |
| Dec 2002 | -$23.98 M(+30.4%) | - | - |
| Dec 2001 | -$18.39 M(+33.3%) | - | - |
| Dec 2000 | -$13.79 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual operaing income?
- What is the all time high annual operating profit for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual operating profit year-on-year change?
- What is Cytokinetics Incorporated quarterly operating income?
- What is the all time high quarterly operating profit for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly operating profit year-on-year change?
- What is Cytokinetics Incorporated TTM operating income?
- What is the all time high TTM operating profit for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM operating profit year-on-year change?
What is Cytokinetics Incorporated annual operaing income?
The current annual operating profit of CYTK is -$496.20 M
What is the all time high annual operating profit for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual operaing income is $26.07 M
What is Cytokinetics Incorporated annual operating profit year-on-year change?
Over the past year, CYTK annual operaing income has changed by -$172.00 M (-53.05%)
What is Cytokinetics Incorporated quarterly operating income?
The current quarterly operating profit of CYTK is -$140.80 M
What is the all time high quarterly operating profit for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly operating income is $57.60 M
What is Cytokinetics Incorporated quarterly operating profit year-on-year change?
Over the past year, CYTK quarterly operating income has changed by -$18.54 M (-15.16%)
What is Cytokinetics Incorporated TTM operating income?
The current TTM operating profit of CYTK is -$524.63 M
What is the all time high TTM operating profit for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM operating income is $27.31 M
What is Cytokinetics Incorporated TTM operating profit year-on-year change?
Over the past year, CYTK TTM operating income has changed by -$28.81 M (-5.81%)